Table 2.

Adverse events reported during the first year of study

AE type	Patients (n)	Time after injection	Outcome
Hypertension	1	10-15 minutes	Improved 4 hours after using IV propranolol
Tachycardia	3	10-15 minutes	Improved after using IV propranolol
Headache	1	10 minutes	Improved
Dizziness	1	10 minutes	Improved
Dyspnea/tachypnea	2	2 weeks	Improved
Chest pain	2	3 weeks/2 months	Improved
PEG insertion	2	5 months/4 months	NA
Pulmonary emboli	2	3 weeks/2 months	Death
Pneumonia	1	2 weeks	Improved
Death	3	7 months/9 months/6 months	NA

Three patients passed away during the 12 months follow-up. Two death were as a result of pulmonary emboli and the third one was due to the lethal nature of the disease. IV; Intravenous and NA: Not applicable.